POSCO International

POSCO International is a leading South Korean general trading company and a core subsidiary of the POSCO Group. The company has strategically expanded into the life sciences and biotechnology sectors, designating "Bio" as one of its key future growth engines alongside steel and energy. Its healthcare division focuses on the global distribution of medical equipment, pharmaceutical products, and the development of hospital infrastructure projects. Through its investment in Bio-App, POSCO International is involved in the commercialization of plant-based "green" vaccines, including the world's first plant-derived vaccine for Classical Swine Fever. The company utilizes its extensive global network of over 80 overseas branches to facilitate international market entry for innovative biotech products and medical technologies.